为澳大利亚终身免疫接种登记系统的设计提供信息
2016年澳大利亚召开全国研讨会,邀请政府、疫苗使用者和提供者等关键利益相关方,审视澳大利亚免疫接种登记系统(AIR)的理想特征以确保最优效果。研讨会聚焦识别新纳入登记系统的人群并支持其实现高免疫覆盖的功能需求。关键建议包括双向数据流、系统化捕获准确完整数据以确定亚人群分母、与其他政府数据集链接、捕获免疫接种后不良事件以及方便患者、提供者和研究人员访问。部分建议已整合入当前版AIR,数据准确性和有效性通过数据录入控制、完整性检查和报告要求得到改善,但研究访问AIR数据仍漫长且昂贵,限制了研究潜力。
要点
- 研讨会建议AIR与提供者之间实现双向数据流。
- 需系统化捕获准确完整数据以确定亚人群分母,包括原住民和托雷斯海峡岛民身份、医学风险因素、职业、 ethnicity、出生国和孕期接种疫苗。
- 部分建议已整合入当前AIR,数据准确性和有效性通过数据录入控制、完整性检查和报告要求得到改善。
核心结论
- 研讨会的部分建议已为AIR的开发和未来效用提供信息,部分建议已整合入当前版AIR。
研究设计与样本
- 2016年召开全国研讨会,关键利益相关方来自政府、新疫苗和现有疫苗使用者以及疫苗提供者,审查AIR的理想特征以确保最优效果。
主要发现
- 关键建议包括AIR与提供者之间双向数据流、系统化捕获准确完整数据以确定亚人群分母、与其他政府数据集链接、捕获免疫接种后不良事件以及方便患者、提供者和研究人员访问。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究访问AIR数据仍漫长且昂贵,限制了研究潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In 2016, Australia launched a whole life immunisation register, the Australian Immunisation Register (AIR), building on a universal childhood register established in 1997. Immunisation Information Systems are well established in Europe, the US and elsewhere. However, a national system covering immunisation across the lifespan, with complete capture of the population and satisfactory data quality, is rare. METHODS: A national workshop was convened in 2016 with key stakeholders from the government, new and existing vaccine users, and vaccine providers to review the ideal features of the AIR to ensure optimal effectiveness. This workshop focused on the functionality needed to identify population groups newly included in the register and support the achievement of high immunisation coverage in these groups eligible for National Immunisation Program vaccines. RESULTS: Key recommendations included the need for bidirectional data flow between the AIR and providers; systematic approaches to the capture and recording of accurate and complete data to ascertain important denominators for subpopulations, includingAboriginal and Torres Strait Islander status, medical risk factors, occupation, ethnicity, country of birth, and vaccines given during pregnancy; linkage with other government datasets including notifiable diseases; the capture of adverse events following immunisation; ease of access by patients, providers; and by researchers. CONCLUSIONS: Some recommendations from the workshop have informed the development and future utility of the AIR. Some recommendations from the workshop have been integrated into the current iteration of the AIR, which is more important than ever given the roll-out of COVID-19 vaccines. The accuracy and validity of data have subsequently improved through data entry controls, data integrity checks and reporting requirements. Access to AIR data for research remains protracted and costly, limitingresearch potential.
引用
- Kpozehouen EB, Heywood AE, Menzies R, et al. Informing the design of a whole of life immunisation register for Australia. Vaccine. 2023. PMID: 37037706. doi:10.1016/j.vaccine.2023.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。